Du Yu, Zhu Yong, Liu Yan, Liu Jinxing, Hu Chengping, Sun Yan, Zhang Dai, Lv Sai, Cheng Yujing, Han Hongya, Zhang Jianwei, Zhao Yingxin, Zhou Yujie
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing100029, China.
Curr Vasc Pharmacol. 2022;20(2):189-200. doi: 10.2174/1570161120666220114095320.
Given its close anatomical location to the heart and its endocrine properties, attention on epicardial adipose tissue (EAT) has increased.
This study investigated the expression profiles of long noncoding RNAs (lncRNAs) and messenger RNAs (mRNAs) in EAT derived from patients with coronary artery disease (CAD).
EAT samples from 8 CAD, and 8 non-CAD patients were obtained during open-heart surgery, respectively. The expression of lncRNAs and mRNAs in each EAT sample was investigated using microarray analysis and further verified using reverse transcription-quantitative polymerase chain reaction.
Overall, 1,093 differentially expressed mRNAs and 2,282 differentially expressed lncRNAs were identified in EAT from CAD vs. non-CAD patients. Analysis using Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes showed that these differentially expressed genes were mainly enriched in various inflammatory, immune, and metabolic processes. They were also involved in osteoclast differentiation, B cell receptor and adipocytokine signaling, and insulin resistance pathways. Additionally, lncRNA-mRNA and lncRNA-target pathway networks were built to identify potential core genes (e.g., Lnc-CCDC68-2:1, AC010148.1, NONHSAT104810) involved in atherosclerotic pathogenesis.
In summary, lncRNA and mRNA profiles in EAT were markedly different between CAD and non-CAD patients. Our study identifies several potential key genes and pathways that may participate in atherosclerosis development.
鉴于心外膜脂肪组织(EAT)与心脏在解剖位置上相近且具有内分泌特性,对其的关注日益增加。
本研究调查了冠状动脉疾病(CAD)患者来源的EAT中长链非编码RNA(lncRNA)和信使RNA(mRNA)的表达谱。
分别在心脏直视手术期间获取8例CAD患者和8例非CAD患者的EAT样本。使用微阵列分析研究每个EAT样本中lncRNA和mRNA的表达,并通过逆转录定量聚合酶链反应进一步验证。
总体而言,在CAD患者与非CAD患者的EAT中鉴定出1093个差异表达的mRNA和2282个差异表达的lncRNA。使用基因本体论和京都基因与基因组百科全书进行分析表明,这些差异表达的基因主要富集于各种炎症、免疫和代谢过程。它们还参与破骨细胞分化、B细胞受体和脂肪细胞因子信号传导以及胰岛素抵抗途径。此外,构建了lncRNA-mRNA和lncRNA-靶标途径网络,以鉴定参与动脉粥样硬化发病机制的潜在核心基因(例如,Lnc-CCDC68-2:1、AC010148.1、NONHSAT104810)。
总之,CAD患者与非CAD患者的EAT中lncRNA和mRNA谱存在明显差异。我们的研究鉴定出了几个可能参与动脉粥样硬化发展的潜在关键基因和途径。